Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian “tumor of breast tissue: incidence, genetics, and environmental risk factors” study
✍ Scribed by Uwe Langsenlehner; Gerald Wolf; Tanja Langsenlehner; Armin Gerger; Günter Hofmann; Heimo Clar; Thomas C. Wascher; Bernhard Paulweber; Hellmut Samonigg; Peter Krippl; Wilfried Renner
- Publisher
- Springer US
- Year
- 2007
- Tongue
- English
- Weight
- 182 KB
- Volume
- 109
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Vascular endothelial growth factor (VEGF), the key mediator of angiogenesis, plays an important role in the development of different kind of tumors, including gastric cancer (GC). The aim of this study is to test the hypothesis that genetic variants of __VEGF__ are associated with risk
## Abstract ## BACKGROUND In addition to possessing many physiologic functions, human growth hormone‐1 (GH1) has been shown in recent in vitro and in vivo experiments to induce malignant disease, including breast carcinoma. The authors investigated the association of breast carcinoma with genetic
## Abstract Insulin‐like growth factor‐1 (IGF‐I), a potent mitogen, is hypothesized to influence breast cancer risk. In 3 previous studies, a polymorphism in the __IGF‐1__ gene (sequence repeat length) was associated with plasma IGF‐I level. We evaluated prospectively the relationships among a (CA)